Additionally, prior research has shown that Aβ deposits in the preclinical phase are the strongest predictors of tau accumulation (Ossenkoppele et al., 2021), which has been demonstrated to affect cortical atrophy in the course of AD (Harrison et al., 2019). Here, MAPT is linked to Alzheimer disease.